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BACKGROUND: Diagnosing iron deficiency anemia (IDA) is easy, but also can be complicated in condition with inflammation. A new modality 
for diagnostic which isn’t influenced with inflammation is 
needed. The aim of this study is to find the cut-off point 
and evaluate the accuracy of reticulocyte hemoglobin 
equivalent (Ret-He)  to  diagnose  IDA  using ferritin as the 
gold standard. 
METHODS: This study was an observational study 
with cross-sectional analytical design continued with the 
diagnostic test conducted in anemic individuals with age 18 
years old or above.
RESULTS: Eighty-seven patients (41 men and 46 women) 
were included in this study with mean of hemoglobin 7.42 
g/dL, serum iron 42.71 mg/dL,  total iron-binding capacity 
(TIBC) 242.82 mg/dL, ferritin 799 ug/L and Ret-He 23.63 
pg. Ret-He with cut-off value 25 pg showed a sensitivity 
97.2% (95% CI 83.79-99.85%), specificity 66.67% (95% CI 
51.97-78.85%), positive predictive value 67.30% (95% CI 
52.77-79.28%) and negative predictive value 97.14% (95% 
CI 83.38-99.85%). 
CONCLUSION: Ret-He showed the best sensitivity for 
detection of IDA and was suggested as the screening test 
for IDA.
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Abstract
Introduction
Iron deficiency anemia (IDA) has been a big problem in 
the world and also in Indonesia. World Health Organization 
(WHO) in 2005 estimated that approximately 24.8% of 
the global population affected by IDA.(1) Indonesia Basic 
Health Research in 2007 showed the prevalence of anemia 
in several periods of age or conditions, 59% in pregnant 
women, 70.1% in children, 59.9% in childbearing-age 
woman and 33.4% in male.(2) Based on a which specifically 
examined the prevalence of IDA in pregnant women in Bali, 
46.2% of pregnant women suffered from mild IDA.(3) The 
impacts of iron deficiency include motor and cognitive 
development interruption, metabolic disorders, decreased 
endurance and other negative impacts.(4)
  IDA is anemia arising from depleted body iron 
reserves (depleted iron stores) so that the supply of iron 
for erythropoiesis is reduced, and ultimately the formation 
of hemoglobin is decreased.(5) The gold standard in 
the diagnosis of IDA is bone marrow staining to find 
hemosiderin. But due to several constraints, such as highly 
invasive procedures, inter-examiner variability and cost 
constraints, this test is being replaced. Ferritin is the best 
test in assessing the iron reserves.(6,7) However, Ferritin is 
an acute phase protein, and the levels will be affected by a 
chronic inflammatory condition.(6-10) Now the world needs 
a new and easier modality to diagnose IDA. Reticulocyte 
hemoglobin equivalent (Ret-He) is a new test that measures 
the incorporation of iron in hemoglobin and reticulocytes. 
Ret-He can produce direct estimates of the availability of 
iron in erythron, which is expected to provide an easier way 
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Methods
Results
Table 1. Sample characteristics (n=87). 
Table 2. Laboratory result parameter  from all samples.
This study was a cross-sectional diagnostic study to 
determine the accuracy of Ret-He in diagnosing IDA 
compared with ferritin <20 μg/L  as gold standard according 
to Kerlin’s Criteria. This research was conducted in subjects 
with anemia hemoglobin level <10 gr/dL aged over 18 
years who signed the informed consent in Sanglah Central 
General Hospital and Bangli Regency General Hospital 
from November 2015 through January 2016. Samples were 
taken consecutively until the number of samples met with 
minimal samples, which is 82. 
 Blood samples were collected using ethylenediamine 
tetraacetic acid anticoagulant tubes (Vacutainer TM 
Becton-Dickinson, Rutherford, NJ, USA). Sysmex XN 
series is a fully automated blood cell counter. A sodium 
lauryl sulfate hemoglobin method was used to examine 
hemoglobin, hematocrit and erythrocyte index and a flow-
cytometry method using semi-conducted laser used to 
measure Ret-He. Serum iron, total iron-binding capacity 
(TIBC) and ferritin were measured by using Immulite 2000 
with immunochemiluminescent. The data were analyzed 
by using SPSS 16.0. Normality test was done by using 
Kolmogorov-Smirnov test. The diagnostic test was done to 
get the sensitivity, specificity, positive predictive value and 
negative predictive value.  Type of anemia was taken from 
the history and primary diagnosis of the patient.
A total of 87 samples of patients were included in this study 
in which there were 41 (47.1%) of male patients and 46 
(52.9%) female patients. The average age of patients was 46 
years. More patient characteristics were shown in Table 1. 
 The distribution of data by Kolmogorov-Smirnov test 
of age, hemoglobin, hematocrit, mean corpuscular volume, 
mean corpuscular hemoglobin, reticulocyte, Ret-He, serum 
iron, TIBC, ferritin, and transferrin saturation showed a 
normal distribution (Table 2).
 A diagnostic test with a 2x2 table was used to assess 
the sensitivity, specificity, positive predictive value, negative 
Characteristics n (%)
Age (years) 46.89 ± 18.49
Gender
Male 41 (47.1)
Female 46 (52.9)
Education
No education 14 (16.1)
Elementary and high school 63 (72.4)
Bachelor 10 (11.5)
Type of work
Non-working and housewife 40 (45.5)
Farmer 15 (17.0)
Private sector 21 (23.9)
Professional 11 (12.9)
Anemia Types
IDA 36 (41.4)
ACD 20 (34.5)
Anemia in CKD 11 (12.6)
Hemorrhagic anemia 4 (4.6)
Mielosuppresion anemia 1 (1.1)
Hemolytic anemia 2 (2.3)
Anemia in cancer 3 (3.4)
*IDA: Iron Deficiency Anemia; ACD: Anemia of Chronic Disease; 
CKD: Chronic Kidney Disease
Laboratory Results Parameter Value (SD)
Hb (mg/dL) 7.42 (1.73)
Hct (%) 23.66 (5.70)
MCV (fL) 75.48 (11.61)
MCH (pg) 23.75 (5.38)
SI (μg/dL) 42.71 (49.56)
TIBC (μg/dL) 248.82 (117.41)
Transferin saturation (%) 22.08 (26.66)
Feritin  (μg/dL) 822.50 (1843.15)
Ret-He (pg) 23.63 (6.75)
Reticulocyte 0.99 (0.77)
to diagnose IDA.(11)  The absence of standardization of 
the cut-off is a constraint of using the Ret-He to diagnose 
IDA. The current study aims for accuracy value of Ret-
He (sensitivity, specificity, positive predictive value and 
negative predictive value) using the cut-off value from 
several studies. The study by Canals used Ret-He cut-off 
value <25 pg to distinguish between IDA and anemia of 
chronic disease (ACD). A study was conducted in chronic 
hemodialysis patient to diagnose iron deficient condition 
using Ret-He 27.2 pg as the cut-off point. Meanwhile, 
study by Urrechaga used Ret He <29 pg to diagnose iron 
deficiency anemia in adult patients.(11-15) All of this cut-
off points were tested in this study. 
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predictive value, positive likelihood ratio and negative 
likelihood ratio. The cut-off was based on some studies that 
have been published, where 25 pg, 26 pg, 27.2 pg and 29 pg 
cut-off were analyzed tested in this study. Tables 3 through 
Table 6 described the results of the diagnostic test examined 
in this study.  
 Based on the analysis by using cross table 2x2, Ret-
He <25 pg showed the best sensitivity, specificity, positive 
predictive value and negative predictive value compared to 
the other cut-off. The value showed that the sensitivity was 
97.2% (95% CI: 83.79-99.85%), specificity was 66.67% 
(95% CI: 51.97-78.85%), positive predictive value was 
67.30% (95% CI: 52.77-79.28%) and negative predictive 
value was 73.81% (95% CI 57.96-86.14%).
Low Normal
<25 pg 35 17 52
≥25 pg 1 34 35
36 51 87
Sensitivity
Specificity
Positive predictive value
Negative predictive value
: 97.2% (95% CI: 83.19-99.85%)
: 66.67% (95% CI: 51.97-78.85%) 
: 67.30% (95% CI: 52.77-79.28%)
: 97.14% (95% CI: 83.38-99.85%)
Ret_He
Total
Ferritin
Total
Table 3. Diagnostic test between Ret-He and ferritin with cut-
off Ret-He <25 pg.
Low Normal
<26 pg 35 20 55
≥26 pg 1 31 32
36 51 87
Specificity : 60.78% (95% CI: 46.12-73.82%) 
Positive predictive value : 63.63% (95% CI: 49.51-75.85%)
Negative predictive value : 96.87% (95% CI: 82-99.83%)
Ferritin
Total
Ret_He
Total
Sensitivity : 97.2% (95% CI: 83.79-99.93%) 
Table 4. Diagnostic test between Ret-He and ferritin with cut-
off Ret-He <26 pg.
Low Normal
<27 pg 35 25 60
≥27 pg 1 26 27
36 51 87
Specificity : 50.98% (95% CI: 36.6-60.25%) 
Positive predictive value : 58.33% (95% CI: 44.88-70.83%)
Negative predictive value : 96.30% (95% CI: 81.03-99.91%)
Ferritin
Total
Ret_He
Total
Sensitivity : 97.22% (95% CI: 85.47-99.93%) 
Table 5. Diagnostic test between Ret-He and ferritin with cut-
off Ret-He <27 pg.
Low Normal
<29 pg 36 28 64
≥29 pg 0 23 23
36 51 87
Specificity : 45% (95% CI: 31.38-59.54%)
Positive predictive value : 56.25% (95% CI: 43.82-68.41%)
Negative predictive value : 100% (95% CI: 82.19-100%)
Ferritin
Total
Ret_He
Total
Sensitivity : 100% (95% CI: 87.99-100%) 
Table 6. Diagnostic test between Ret-He and ferritin with cut-
off Ret-He <29 pg.
In the Ret-He <25 pg value obtains the figure of sensitivity, 
specificity, positive predictive value and negative predictive 
value that is best compared with other cut-off values taken 
Discussion
from other studies. This result is different compared to 
studies conducted by Canals, et al., which were obtained by 
the specificity and sensitivity of 81% and 76%. Studies by 
Canals aimed to determine cut-off values of Ret-He and to 
determine its role in distinguishing between IDA and ACD. 
Canals strength of the study was a diagnostic test performed 
only on IDA and ACD groups to obtain a higher specificity 
value and also a greater number of samples, which was 504 
subjects involved in the study with 127 subjects of them 
suffered from iron deficiency. Meanwhile, in this study a 
fewer number of patients with anemia (hemoglobin <10 gr/
dL) was involved and we classified the anemia into seven 
types of anemia including ACD and IDA. That was why the 
sensitivity values obtained in this study was better than the 
study conducted by Canals.(14)
 Studies by Hatoun using a cut-off value of higher 
Ret-He, that was <27.2 pg because the study aimed 
to screen  for  iron  deficiency  conditions  before  IDA 
occurred.(15) Likewise on studies conducted by Urrechaga 
which used the value of Ret-He <29 pg because it was 
used to detect iron-restricted conditions erythropoiesis 
146
The Indonesian Biomedical Journal, Vol.9, No.3, December 2017, p.143-6 Print ISSN: 2085-3297, Online ISSN: 2355-9179
Conclusion
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